SIC
XBI icon

Salem Investment Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Salem Investment Counselors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$661K Hold
4,176
– – 0.02% 280
2026
Q1 		$533K Hold
4,176
– – 0.02% 279
2025
Q4 		$509K Hold
4,176
– – 0.01% 279
2025
Q3 		$418K Hold
4,176
– – 0.01% 301
2025
Q2 		$346K Sell
4,176
-425
-9% -$33.9K 0.01% 315
2025
Q1 		$373K Hold
4,601
– – 0.01% 285
2024
Q4 		$414K Hold
4,601
– – 0.01% 281
2024
Q3 		$455K Sell
4,601
-250
-5% -$24.6K 0.01% 281
2024
Q2 		$450K Hold
4,851
– – 0.01% 274
2024
Q1 		$460K Hold
4,851
– – 0.02% 271
2023
Q4 		$433K Sell
4,851
-6,000
-55% -$446K 0.01% 269
2023
Q3 		$792K Sell
10,851
-300
-3% -$24K 0.03% 194
2023
Q2 		$928K Hold
11,151
– – 0.03% 182
2023
Q1 		$850K Hold
11,151
– – 0.03% 190
2022
Q4 		$926K Sell
11,151
-225
-2% -$18.2K 0.04% 189
2022
Q3 		$902K Sell
11,376
-697
-6% -$58.8K 0.04% 180
2022
Q2 		$897K Sell
12,073
-489
-4% -$36.7K 0.04% 188
2022
Q1 		$1.13M Sell
12,562
-1,456
-10% -$134K 0.04% 180
2021
Q4 		$1.57M Sell
14,018
-487
-3% -$58.7K 0.05% 155
2021
Q3 		$1.82M Hold
14,505
– – 0.1% 143
2021
Q2 		$1.96M Sell
14,505
-500
-3% -$65.7K 0.11% 138
2021
Q1 		$2.04M Buy
15,005
+697
+5% +$104K 0.12% 126
2020
Q4 		$2.01M Buy
14,308
+2
+0% +$256 0.13% 122
2020
Q3 		$1.59M Buy
14,306
+1,400
+11% +$157K 0.12% 120
2020
Q2 		$1.45M Buy
12,906
+56
+0.4% +$5.51K 0.12% 121
2020
Q1 		$995K Hold
12,850
– – 0.1% 134
2019
Q4 		$1.22M Sell
12,850
-105
-0.8% -$9.08K 0.1% 136
2019
Q3 		$988K Sell
12,955
-3,550
-22% -$295K 0.09% 140
2019
Q2 		$1.45M Buy
+16,505
New +$1.41M 0.13% 126
2017
Q2 		– Sell
-11,950
Closed -$829K – 787
2017
Q1 		$829K Sell
11,950
-1,200
-9% -$80.6K 0.09% 148
2016
Q4 		$778K Sell
13,150
-4,500
-25% -$278K 0.09% 143
2016
Q3 		$11.7K Buy
17,650
+175
+1% +$10.8K 0.15% 113
2016
Q2 		$945K Sell
17,475
-3,024
-15% -$166K 0.11% 137
2016
Q1 		$1.06M Sell
20,499
-5,100
-20% -$265K 0.13% 128
2015
Q4 		$1.79M Hold
25,599
– – 0.23% 97
2015
Q3 		$1.58M Sell
25,599
-8,946
-26% -$705K 0.21% 102
2015
Q2 		$2.9M Buy
34,545
+510
+1% +$39.7K 0.35% 76
2015
Q1 		$2.56M Buy
+34,035
New +$2.38M 0.31% 83

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
OPCM
Osborne Partners Capital Management San Francisco, California $1.8B AUM 22.23% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

Salem Investment Counselors's XBI Position: Q2 2026 in Review

Salem Investment Counselors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 4,176 shares worth $661K. The position accounts for 0.02% of the portfolio, ranked #280.

Salem Investment Counselors first reported a position in XBI in Q1 2015 and has held it in 38 quarters since. The position peaked at $2.9M in Q2 2015. 447 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Salem Investment Counselors held 4,176 shares of State Street SPDR S&P Biotech ETF worth $661K as of Q2 2026.
  • Salem Investment Counselors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Salem Investment Counselors's portfolio in Q2 2026, its #280 holding.
  • Salem Investment Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 38 quarters since.
  • Salem Investment Counselors's State Street SPDR S&P Biotech ETF position peaked at $2.9M in Q2 2015.
  • 447 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.